Laura Evans is a highly skilled scientist specializing in molecular oncology, with vast experience in target identification and development. Currently serving as an Associate Principal Scientist at Bayer since 2024, they previously worked as a Research Scientist in Oncology at Bayer Pharmaceuticals from 2020 to 2024. Laura completed a PhD at the Newcastle Cancer Centre from 2010 to 2014, where they identified SKP2 as a MYCN target gene and collaborated with structural biologists on novel small molecule synthesis. They also held a postdoctoral fellowship at the Dana-Farber Cancer Institute from 2015 to 2020. Laura earned a 2.1 degree in Biochemistry and Biological Chemistry from the University of Nottingham and a distinction in MRes in Biomedical and Biological Science from Newcastle University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices